Table 1.
Agent | Effects on the blood–brain barrier |
---|---|
Dimethyl fumarate | ↓ expression of adhesion molecules (VCAM-1 1, ICAM-1 2) [84] |
Laquinimod | ↓ expression of adhesion molecule ICAM-1 [102] ↓ expression of MMP-9 [103] |
Fingolimod | ↓ S1P1/S1P3 4 expression on the surface of the endothelial cells [110,111] ↓ VEGF 5 and ↓ vascular permeability [112] |
Cladribine | ↓ICAM-1, E-selectin ↓ MMP-2, -9 [136,139] |
Natalizumab | Blocks the interaction between the α-4 integrin (lymphocyte surface) and VCAM-1 (endothelial surface) [73] |
Interferon-beta | Ensures structural BBB stability in murine models [69,70,71] |
Cortisone | ↓ expression of adhesion molecules (VCAM-1, ICAM-1, E selectin) [144,148] ↓ MMP-1 and -9 [149] ↑ up-regulation of TJ (occludine, claudin) [150,151] |
1 Vascular cell adhesion molecule, 2 Intracellular Adhesion Molecule, 3 Matrix Metalloproteinase, 4 Sphingosine-1-Phosphate receptor, 5 Vascular Endothelial Growth Factor.